Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating enrollment is closed for this study. The page also adds new help and navigation content ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and related topic links, while the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T16:31:36.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays the latest site revision, 'Revision: v3.5.5', replacing the previous 'Revision: v3.5.4'. It also removes references to 'Type 2 diabetes' and 'related topics: MedlinePlus Genetics'.
    Difference
    0.1%
    Check dated 2026-06-05T13:21:29.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now includes additional related-topic links for Type 2 diabetes and MedlinePlus Genetics under the related topics section, expanding access to diabetes and genetics resources.
    Difference
    0.1%
    Check dated 2026-05-29T10:00:23.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page no longer displays the disease term 'Type 2 diabetes' in the study description and the Related Topics section has been removed, including the 'MedlinePlus Genetics' item. This reflects removal of a core disease descriptor and its related resources, affecting how the study is framed and navigated.
    Difference
    0.1%
    Check dated 2026-05-22T09:42:29.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.4, replacing the previous Revision: v3.5.3, indicating a small release update.
    Difference
    0.0%
    Check dated 2026-05-15T05:44:56.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page footer has been updated to reflect a newer ClinicalTrials.gov interface/version revision (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-24T05:46:50.000Z thumbnail image

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.